2015 Washington DC GOC Meeting Agenda

Please plan to join us this fall from August 30th through September 2nd for the next meeting of the Gene Ontology Consortium. We will host the meeting at the Marvin Conference Center, George Washington University, at the heart of Washington, DC.

The GOC meeting will be held on August 30-31, 2015.

A GOC Symposium day will be held on September 1, 2015. (Details will be posted here: http://wiki.geneontology.org/index.php?title=2015_Washington_DC_GOC_Symposium_Agenda)

The GOC SAB will convene on September 2, 2015. (Details will be posted here: http://wiki.geneontology.org/index.php/2015_Washington_DC_GOC_Scientific_Advisory_Board_Meeting_Agenda)

Details to follow soon.

Daily schedule

• Start: ??
• Morning coffee break: ??
• Lunch: ??
• Afternoon session: ??
• Afternoon coffee break: ??

Minutes

http://wiki.geneontology.org/index.php?title=2015_Washington_DC_GOC_Meeting_Minutes

Agenda for the main GOC meeting (August 30-31 2015)

Please ensure that all outstanding items from the trello board are covered here in the agenda under the appropriate heading.

User support and interaction

• GO survey and user experience
• GO enrichment analysis
• GO website and FAQs
• AmiGO
• GO helpdesk
• Protein2GO: 15 min - demo/new features + 5 min discussion (ECO codes) - Tony Sawford and Aleksandra Shypitsyna

Literature Annotation

Proteome sets

• Resolving ID issues (what is in the ref_proteome, what is a gene centric proteome reference proteome, TrEMBL, SwissProt etc)
• https://github.com/geneontology/touchup/issues/14 - how to remedy the change in PAINT files format (we expect uniprot accessions in column 2 and those have been replaced by ensembl IDs)

Traceability of annotations

• When one annotation is derived from another (manually or logically) it would be useful to have an easy way to point back to the existing annotation.

Annotating complexes to GO

(Helen offered to chair this discussion)

• General issues (Sandra)
• Annotation guidance (Rama)
• Ontology issues (David OS?)

Compounding Evidence codes

• Is it possible to do this and is it appropriate? An example of this would be capturing the evidence when a direct enzymatic assay is used to test the loss of function in a mutant enzyme (IDA or IMP).

MicroRNA guideline summary

Brief overview - Rachael Huntley

Resolution on chromatin binding

chromatin binding vs localization to chromatin